Delivery Order SPE2DB24D1205-SPE2DB25FCRML
Award Date
11/7/24
Potential Completion Date
11/8/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML medical products. The contract has a ceiling value of $1,744.62 and a completion date of January 16, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen also holds a separate Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, with a ceiling value of $1,369.81 and a period of performance through November 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, with a ceiling value of $2,002.96. The contract is a firm fixed price, non-set-aside award with a performance period ending on June 11, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, with a ceiling value of $1,809.60 and a period of performance through April 18, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a medical product, with a ceiling value of $2,533.36. The contract has a firm fixed price pricing type and is set to expire on January 29, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, with a ceiling value of $2,141.87 and a completion date of January 28, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The contract has a ceiling value of $1,629.66 and an ultimate completion date of January 16, 2025. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. The contract has a firm-fixed price, with a ceiling value of $2,121.97, and a period of performance through June 26, 2025. The contract is not set aside for any small business designation. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML, a medical product, with a ceiling value of $1,086.44 and a completion date of January 16, 2025. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, with a ceiling value of $1,097.28 and a performance period ending on March 7, 2025. The contract is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...